Pulmatrix, Inc.

    Jurisdiction
    United States
    LEI
    5299002RHCRZ9ST3GN42
    ISIN
    US74584P3010 (PULM)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    0 / 7

    Profile

    Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €316.60K
    Gross margin
    100.0%
    EBIT
    -€6.87M
    EBIT margin
    -2,169.1%
    Net income
    -€6.80M
    Net margin
    -2,149.1%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: November 13, 2014

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 109K $725.41K -200 Sell

    Add to watchlist

    Notifications